MC1690A1 - Nouveaux composes,leur procede de preparation et composition pharmaceutique les contenant - Google Patents

Nouveaux composes,leur procede de preparation et composition pharmaceutique les contenant

Info

Publication number
MC1690A1
MC1690A1 MC851781A MC1782A MC1690A1 MC 1690 A1 MC1690 A1 MC 1690A1 MC 851781 A MC851781 A MC 851781A MC 1782 A MC1782 A MC 1782A MC 1690 A1 MC1690 A1 MC 1690A1
Authority
MC
Monaco
Prior art keywords
preparation
pharmaceutical composition
composition containing
novel compounds
image
Prior art date
Application number
MC851781A
Other languages
English (en)
French (fr)
Inventor
Roy-Archibald Swaringen
Hassan-Ali El-Sayad
David Arthur Yeowell
John-Joseph Savarese
Original Assignee
Wellcome Found
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found, Gen Hospital Corp filed Critical Wellcome Found
Publication of MC1690A1 publication Critical patent/MC1690A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18—Aralkyl radicals
    • C07D217/20—Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Medicinal Preparation (AREA)
  • Jib Cranes (AREA)
  • Cephalosporin Compounds (AREA)
  • Cosmetics (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Fats And Perfumes (AREA)
MC851781A 1984-07-18 1985-07-17 Nouveaux composes,leur procede de preparation et composition pharmaceutique les contenant MC1690A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848418303A GB8418303D0 (en) 1984-07-18 1984-07-18 Compounds

Publications (1)

Publication Number Publication Date
MC1690A1 true MC1690A1 (fr) 1986-07-18

Family

ID=10564058

Family Applications (1)

Application Number Title Priority Date Filing Date
MC851781A MC1690A1 (fr) 1984-07-18 1985-07-17 Nouveaux composes,leur procede de preparation et composition pharmaceutique les contenant

Country Status (30)

Country Link
US (1) US4761418A (hu)
EP (1) EP0181055B1 (hu)
JP (1) JPH0662568B2 (hu)
AT (1) ATE60759T1 (hu)
AU (1) AU574481B2 (hu)
BG (1) BG60411B2 (hu)
CA (1) CA1273341A (hu)
CY (1) CY1687A (hu)
DD (1) DD235638A5 (hu)
DE (2) DE3581699D1 (hu)
DK (1) DK168093B1 (hu)
ES (1) ES8609260A1 (hu)
FI (1) FI85019C (hu)
GB (1) GB8418303D0 (hu)
GE (1) GEP19960468B (hu)
HK (1) HK47593A (hu)
HU (1) HU193996B (hu)
IE (1) IE58138B1 (hu)
IL (1) IL75833A (hu)
LT (1) LT2078B (hu)
LU (1) LU88801I2 (hu)
LV (1) LV5483A3 (hu)
MC (1) MC1690A1 (hu)
MX (1) MX9203667A (hu)
NL (1) NL940023I2 (hu)
NZ (1) NZ212766A (hu)
PL (1) PL146066B1 (hu)
SG (1) SG3493G (hu)
SU (1) SU1468414A3 (hu)
ZA (1) ZA855407B (hu)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5453510A (en) * 1990-07-13 1995-09-26 Burroughs Wellcome Co. Neuromuscular blocking agents
US5240939A (en) * 1991-10-31 1993-08-31 Anaquest, Inc. Nitrogen bridge tetrahydroisoquinolines
US5510355A (en) * 1994-09-06 1996-04-23 Bencherif; Merouane Depolarizing skeletal muscle relaxants
CN1203061C (zh) * 1997-03-25 2005-05-25 艾弗拉药品公司 取代异喹啉类，其制备方法，药物组合物及其制药用途
GB0204087D0 (en) * 2002-02-21 2002-04-10 Legislator 1563 Ltd Di-ester derivatives as short acting neuromuscular blockers
EP1684753A2 (en) * 2003-10-28 2006-08-02 Cornell Research Foundation, Inc. Neuromuscular blocking agents and antagonists thereof
US7872137B2 (en) * 2006-06-20 2011-01-18 Farmabios S.P.A. Process for the preparation of mivacurium chloride
WO2008070121A1 (en) * 2006-12-06 2008-06-12 Cornell Research Foundation, Inc. Intermediate duration neuromuscular blocking agents and antagonists thereof
CA2680277A1 (en) * 2007-03-08 2008-09-12 Chemagis Ltd. (1r,1'r)-atracurium salts separation process
BRPI0808581A2 (pt) * 2007-03-26 2014-09-16 Chemagis Ltd "método para separar cisatracúrio com alta pureza de uma mistura de isômeros de (1r, 1'r) - atracúrio"
CA2685488A1 (en) * 2007-05-01 2008-11-06 Chemagis Ltd. Novel isoquinolinium compounds useful in the preparation of cisatracurium and associated intermediates
US8293912B2 (en) * 2007-05-01 2012-10-23 Chemagis Ltd. Process for producing cisatracurium compounds and associated intermediates
WO2008155752A1 (en) * 2007-06-18 2008-12-24 Chemagis Ltd. (1r,1'r)-atracurium salts separation process
US20100256381A1 (en) * 2007-07-09 2010-10-07 Chemagis Ltd. Process for producing cisatracurium and associated intermediates
EP2197848A1 (en) * 2007-10-29 2010-06-23 Chemagis Ltd. Novel r,r'-atracurium salts
ITMI20080319A1 (it) * 2008-02-28 2009-08-29 Recordati Chem Pharm Processo per la risoluzione di derivati isochinolinici
CA2722651A1 (en) * 2008-05-01 2009-11-05 Chemagis Ltd. Cisatracurium derivatives, preparation and uses thereof
US8592451B2 (en) 2009-03-17 2013-11-26 Cornell University Reversible nondepolarizing neuromuscular blockade agents and methods for their use
US9220700B2 (en) 2009-08-19 2015-12-29 Cornell University Cysteine for physiological injection
WO2013021398A2 (en) * 2011-08-05 2013-02-14 Sequent Scientific Limited A process for preparation of mivacurium chloride
US9156826B2 (en) 2012-06-29 2015-10-13 Cornell University Asymmetrical reversible neuromuscular blocking agents of ultra-short, short, or intermediate duration
CN103373959A (zh) * 2013-06-14 2013-10-30 安徽省先锋制药有限公司 顺式苄基异喹啉类化合物的制备方法及其用途
CN107782821B (zh) * 2016-08-26 2021-11-09 四川科瑞德制药股份有限公司 一种神经肌肉阻滞剂的分析方法
CN107778237A (zh) * 2016-08-26 2018-03-09 四川科瑞德制药股份有限公司 一种神经肌肉阻滞剂中间体的新晶型及其制备方法和用途
CN108938573B (zh) * 2017-05-26 2021-08-10 四川科瑞德制药股份有限公司 一种神经肌肉阻滞剂组合物及其制备方法和用途
CN108503564A (zh) * 2017-09-30 2018-09-07 武汉嘉诺康医药技术有限公司 一种米库氯铵中间体及利用该中间体合成米库氯铵的方法
CN110361472B (zh) * 2019-07-29 2022-04-29 武汉嘉诺康医药技术有限公司 一种米库氯铵中间体miv-g异构体的hplc检测方法
CN111004179B (zh) * 2019-11-11 2021-03-09 武汉大安制药有限公司 一种5’-甲氧基劳丹素的拆分方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3004031A (en) * 1958-07-03 1961-10-10 Allen & Hauburys Ltd Diquaternary salts of papaverino esters
GB863717A (en) * 1958-07-03 1961-03-22 Allen & Hanburys Ltd Tetrahydropapaverine derivatives and their preparation
AU506657B2 (en) * 1975-12-10 1980-01-17 Wellcome Foundation Limited, The Isoquinoline derivatives
SU862820A3 (ru) 1977-08-01 1981-09-07 Дзе Массачусетс Дженерал Хоспитал (Фирма) Способ получени производных изохинолини
US4192877A (en) * 1977-08-01 1980-03-11 Massachusetts General Hospital Neuromuscular blocking agents
US4235906A (en) * 1978-07-21 1980-11-25 Massachusetts General Hospital Bis-isoquinolinium compounds, compositions and methods of use
CA1125287A (en) * 1978-07-21 1982-06-08 John J. Savarese Bis isoquinolinium compositions and methods of use
US4491665A (en) * 1979-10-19 1985-01-01 Burroughs Wellcome Co. Method of preparing isomers of bis isoquinolinium compounds
CA1153380A (en) 1979-10-19 1983-09-06 Hassan A. El-Sayad Neuromuscular blocking tetrahydroisoquinolinium salts
DE3165714D1 (en) * 1980-12-17 1984-09-27 Wellcome Found Long duration neuromuscular blocking agents, pharmaceutical compositions containing them and processes for their preparation
JPS5899465A (ja) * 1981-11-23 1983-06-13 ザ・ウエルカム・フアウンデ−シヨン・リミテツド イソキノリン誘導体

Also Published As

Publication number Publication date
AU4510885A (en) 1986-01-23
BG60411B2 (bg) 1995-02-28
LU88801I2 (fr) 1996-11-05
IE58138B1 (en) 1993-07-14
GB8418303D0 (en) 1984-08-22
NL940023I2 (nl) 1998-06-02
CA1273341A (en) 1990-08-28
NZ212766A (en) 1988-03-30
ES545319A0 (es) 1986-09-01
IL75833A (en) 1988-11-30
SU1468414A3 (ru) 1989-03-23
MX9203667A (es) 1992-07-31
HU193996B (en) 1987-12-28
IL75833A0 (en) 1985-11-29
ZA855407B (en) 1986-04-30
PL146066B1 (en) 1988-12-31
US4761418A (en) 1988-08-02
LV5483A3 (lv) 1994-03-10
FI85019B (fi) 1991-11-15
DD235638A5 (de) 1986-05-14
DK324985A (da) 1986-01-19
EP0181055A1 (en) 1986-05-14
DK168093B1 (da) 1994-02-07
CY1687A (en) 1993-10-10
DE19675039I2 (de) 2003-01-09
JPS6187666A (ja) 1986-05-06
PL254571A1 (en) 1986-07-15
AU574481B2 (en) 1988-07-07
HK47593A (en) 1993-05-21
ATE60759T1 (de) 1991-02-15
HUT40626A (en) 1987-01-28
FI852807L (fi) 1986-01-19
FI852807A0 (fi) 1985-07-17
LT2078B (lt) 1993-06-15
DE3581699D1 (de) 1991-03-14
JPH0662568B2 (ja) 1994-08-17
ES8609260A1 (es) 1986-09-01
IE851791L (en) 1986-01-18
SG3493G (en) 1993-03-12
NL940023I1 (nl) 1995-01-02
EP0181055B1 (en) 1991-02-06
GEP19960468B (en) 1996-08-29
DK324985D0 (da) 1985-07-17
FI85019C (fi) 1992-02-25

Similar Documents

Publication Publication Date Title
MC1690A1 (fr) Nouveaux composes,leur procede de preparation et composition pharmaceutique les contenant
FR2569402B1 (fr) Derives d'acide 3,5-pyridine-dicarboxylique, procede pour leur preparation et composition pharmaceutique les contenant
DE3562238D1 (en) Substituted sulfonamidobenzamides, antiarrythmic agents and compositions thereof
IL66511A (en) 6alpha-methylprednisolone derivatives,process for their preparation and pharmaceutical preparations containing them
PT82512A (fr) Procede de preparation de derives de quinolylglycinamides ayant activite psychotrope et de compositions pharmaceutiques les contenant
ES8305684A1 (es) Procedimiento para la obtencion de derivados aminopropanolicos de 2-hidroxi b-fenil-propiofenonas.
ZA879280B (en) Basically substituted phenylacetonitriles,their preparation and drugs containing these compounds
HUT45537A (en) Process for producing delta-22 derivatives of ll-f 28249 compounds and pharmaceutical compositions containing them as active components, and insecticide compositions
FR2605004B1 (fr) Nouveaux derives d'amino-acides, leur procede de preparation et composition pharmaceutiques les contenant
HU900753D0 (en) Process for preparation of phenylhydrazones and for pharmaceutical compositions containing them
BE885605A (fr) Derives d'acide benzo(ij)quinolizine-carboxylique-2, utiles notamment comme medicaments antimicrobiens, procede de leur preparation et compositions therapeutiques et formes pharmaceutiques les contenant
OA09201A (fr) "Dérivés sulfonyles de la thiéno-triazolo-diazépine, un procédé pour leur préparation et des compositions thérapeutiques en contenant".
ZA826453B (en) Tricyclic thiazolyloxamic acids and their derivatives,their preparation,and therapeutic agents containing these compounds
OA08237A (fr) Nouveaux dérivés du triazole leur procédé de préparation et les compositions pharmaceutiques les renfermant
OA09139A (fr) Nouveaux dérivés de la carbonyl-2 N, N'-di-(triméthoxy-benzoyle) pipérazine, un procédé pour leur préparation et compositions thérapeutiques en contenant.
FR2517301B1 (fr) Nouveaux n-((n-methyl,n-(aminosulfenyl n,n-disubstitue) carbamoyl)oxy)-thioacetamidates de s-methyle, compositions insecticides, miticides ou nematocides les contenant et procede pour leur preparation
FR2599738B1 (fr) Nouveaux derives de l'acide 4-phenyl 4-oxo 2-butenoique, leur procede de preparation, leur application comme medcaments et les compositions les renfermant
OA09429A (fr) "Nouveaux dérivés de la méthoxycarbonyl-2 N, N'-di-(triméthoxybenzoyle) pipérazine, un procédé pour leur préparation et compositions thérapeutiques en contenant".
FR2650278B1 (fr) Procede de preparation de formes non racemiques de derives de la furo (3,4-c) pyridine, composes ainsi obtenus et compositions therapeutiques en contenant
FR2713643B1 (fr) Nouveaux analogues de l'éburnane, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
FR2381761A1 (fr) Nouveaux derives de 1-piperidine-butanol utiles comme medicaments et procedes pour leur preparation
FR2532314B1 (fr) Nouveau procede de preparation de derives de l'acide 3-quinoleine carboxylique, nouveaux derives halogenes de l'acide 3-quinoleine carboxylique, leur application comme medicaments, les compositions pharmaceutiques les renfermant et les intermediaires nouveaux obtenus

Legal Events

Date Code Title Description
YP Annual fee paid